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Abstract
Background: Heroin injection is associated with health and social problems including hepatitis C
virus (HCV) transmission. Few studies have examined the circumstances surrounding initiation to
heroin injecting, especially current users initiating others. The current study aimed to examine the
age of first heroin use and injection; administration route of first heroin use; relationship to
initiator; the initiation of others among a group of heroin users; and to examine these factors in
relation to HCV status and risk.
Method: Heroin users in Sydney were recruited through needle and syringe programs, a
methadone clinic and snowballing. Participants were interviewed about their own initiation to
heroin use, blood-borne virus risk and knowledge, and whether they had initiated others to heroin
injecting. Information on HCV status was collected via self-report. Data was analysed using
univariate and multivariate statistical techniques for Normally distributed continuous and
categorical data.
Results: The study recruited 399 heroin users, with a mean age of 31 years, 63% were male, 77%
reported heroin as their primary drug and 59% were HCV positive (self-report). Mean age at first
heroin use and injection was 19 and 21 years, respectively. The majority of heroin users
commenced heroin use via injecting (65%), younger users (<25 years, 25–30 years) were less likely
than older users (>30 years) to commence heroin use parenterally. Participants were initiated to
injection mainly by friends (63%). Thirty-seven percent reported initiating others to heroin
injection, but few factors were related to this behaviour. Those with longer heroin using careers
were more likely to report initiating others to heroin injection, but were no more likely to have
done so in the preceding 12 months. Participants who had initiated others were more likely to have
shared injecting equipment (12 vs 23%), but were no more likely to be HCV positive (self-report)
than those who did not.
Conclusion: Interventions to prevent heroin users initiating others to injecting are necessary.
Peer groups may be well positioned to implement such interventions.
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Heroin is one of the most commonly injected illicit sub-
stances worldwide [1,2]. Heroin injection is associated
with a range of harms including poor health [3,4], poor
psychosocial functioning [5] and increased risk of fatal
and non-fatal heroin overdose [6,7]. Heroin injection is
also a significant risk factor for blood-borne viral infec-
tions (BBVI) such as hepatitis C, hepatitis B and HIV [8-
12]. Despite these harms little is known about initiation
to heroin injecting.
Hepatitis C is probably the most prevalent health infec-
tion among injecting drug users (IDU) worldwide. The
prevention of hepatitis C has proven difficult; unlike hep-
atitis B there is currently no vaccine available and pro-
grams which have been successful in reducing HIV have
had only a small impact on the HCV epidemic [13,14]. It
has therefore increasingly been acknowledged that pre-
vention of initiation to drug injection is likely to be one of
the most effective prevention strategies for blood-borne
viral transmission [15]. Heroin injecting in particular is
associated with increased HCV prevalence compared to
injection of amphetamine – the two most commonly
injected drugs in Australia [16].
A decrease in the age of initiation to drug use, including
heroin use, across birth cohorts has been documented in
both Australia [17,18] and the United States [19]. This
decrease in the age of heroin initiation has been associ-
ated with greater poly drug use, unintentional overdose
and criminal behaviour, independent of years of heroin
use [17]. Better understanding of the circumstances sur-
rounding initiation to injecting heroin use is needed if
appropriate interventions are to be formulated.
Crofts et al. examined a number of factors surrounding
initiation to injecting among a group of young, recently
initiated IDUs [20]. They found that the majority of their
sample had instigated the first injecting episode, but were
assisted or injected by friends; only a very small propor-
tion were injected by a family member. The research also
found that more females than males reported being
injected by their partner, a pattern consistent with the lit-
erature in that females are more likely than males to have
an IDU sex partner and are less likely to be able to inject
themselves [21-23]. A recent Canadian study of street
youth also found that females were more likely than
males to be injected by their partner or lover [24]. How-
ever, research from the United States found only 13% of
IDU interviewed were initiated by their sex partner, with
no difference between males and females; indeed females
were more likely to be initiated by another female [25].
Little attention has been paid to the initiation of others
into injecting [15]. One small study of a brief intervention
to prevent initiation to injecting found that 40% of the 86
IDU interviewed had initiated a mean of two people to
injecting [26]. Crofts et al. found that 47% of recently ini-
tiated IDUs had also initiated another into injecting and
of those who had, few informed new initiates of BBVI risk
[20]. The relationship between initiators' BBVI status and
risk behaviour was not reported, so it was not possible to
determine whether those engaging in risky behaviours
were more or less likely to initiate others to injecting.
Moreover, the study focused on young or recently initi-
ated injectors, so the role of age and experience in initiat-
ing others to injecting was unable to be determined.
Crofts and colleagues found that the majority of recently
initiated IDU were aware of HIV and hepatitis B and that
the viruses could be transmitted via shared injecting
equipment [20]. A much smaller proportion knew of
HCV, though those who were aware of the virus were also
aware that it could be transmitted via shared injecting
equipment [20]. However, information on serostatus or
hepatitis B vaccination status was not reported, nor was
injecting risk behaviours such as needle and syringe
sharing.
This study examined initiation to heroin injection. Specif-
ically the study aimed to examine: 1) age of first heroin
use and first heroin injection; 2) route of first heroin use;
3) relationship to initiator; and 4) the initiation of others
among a group of heroin users. These factors were then
examined in relation to demographic variables such as




Heroin users in Sydney were volunteers recruited through
needle and syringe programs and a methadone clinic. In
order to sample a range of heroin users, snowballing,
facilitated by a peer interviewer, was also used. Drug users
were eligible to participate if they reported the use of her-
oin at least once a month in the preceding six months. All
participants gave informed consent to be interviewed and
received AUD20 for travel expenses.
Measures
A structured questionnaire was administered to partici-
pants by trained interviewers. Information was sought on
blood-borne virus status and knowledge, and initiation to
heroin use and included questions on age of first heroin
use, age of first heroin injection, relationship to initiator
and the number of times participants had initiated others
to injecting.
Information on HCV status was collected via self-report.
Self-reported HCV status has a concordance ofPage 2 of 7
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[27,28]. For the purposes of this study, self-reported HCV
is relevant as risk behaviour is influenced by the belief
about one's status, not actual status [29].
To determine ethnicity, participants were asked how they
identified ethnically, those identified as being of Aborigi-
nal or Torres Strait Islander decent were categorised as
Indigenous, those not born in Australia and those born in
Australia but who identified as belonging to another eth-
nic group were categorised as 'other Australian'.
The study was approved by four institutional ethics com-
mittees: University of New South Wales Human Research
Ethics Committee, Central Sydney Area Health Service
Ethics Review Committee, South Western Sydney Area
Health Service Research Ethics Committee, and South
Eastern Sydney Area Health Service Research Ethics
Committee.
Analysis
Continuous variables were assessed using t-tests and one-
way analysis of variance. Linear regression was employed
to test the relationship between continuous variables. The
chi square (χ2) statistic was used for univariate analysis of
categorical data. Multiple logistic regression, using back-
ward elimination, was used for multivariate analysis to
examine independent relationships between dichoto-




The sample consisted of 399 heroin users, of whom 63%
were male. The mean age of participants was 31 years (SD
8.2, range 17, 58). The majority of participants were born
in Australia (78%), a small proportion of which identified
as another ethnic group. Participants were categorised as
either 'Australian' (67%), Indigenous (17%) or 'other-
Australian' (16%). The majority (81%) of participants
had attended secondary school, but only 42 (11%) partic-
ipants had tertiary education. Thirty-four (9%) partici-
pants had completed primary (elementary) school only.
Sixty-one percent of participants had a history of
incarceration.
Heroin was the primary drug used by 77% of the sample,
with a median of 9.5 (range <1, 39) years of use and
injecting. The majority (98%) of the sample injected her-
oin; 14% of the sample had been injecting heroin for
three years or less and 80% for more than three years (18
cases had missing data for this variable). Those who did
not inject heroin were excluded from analysis pertaining
to injecting.
Age of initiation to heroin use and injection
The mean age at first heroin use was 19 years, (SD 6.0,
range 9–43 years) and the mean age of first injection was
21 years (SD 6.3, range 13–43 years). The mean age of first
heroin use and first heroin injection was similar for males
(18 years for both) and females (18 and 19 years, respec-
tively). There were no differences in terms of ethnicity for
either age of first heroin use (18 years for all groups) or
first heroin injection (18, 19 and 18 years for Australians,
'other Australians' and Indigenous Australians
respectively).
For those who completed primary school only, the mean
age of first heroin use was 17 (SD 5.4) years and 19 (SD
6.0) years for those who attended secondary school or
above, the difference failed to reach significance (t395 = -
1.89, p = .0.56). Participants who completed primary
school only, were a mean age of 17 (SD 4.8) years when
they first injected heroin and the mean age of first injec-
tion for those who attended secondary school and above
was 20 (SD 6.3) years (t386 = -2.46, p = .014).
Linear regression was used to examine the relationship
between current age and age of initiation to heroin use
and injecting. There was a significant relationship
between participants' current age and age of first heroin
use (β = 0.41, p < .001). Similarly, current age and age of
first injection were also significantly related (β = 0.39, p <
.001).
Route of first heroin administration
Heroin was most commonly first administered by injec-
tion (65%). For the 141 participants who used non-
parenteral routes of administration on initiation of heroin
use, the most common method was smoking (burning
and chasing), with 28% of the sample reporting initiating
heroin use with this method. Only seven percent first used
heroin intranasally, orally or by other means.
Participants who first injected heroin and those who first
used heroin non-parenterally, commenced heroin use at
similar ages (19 and 20 years, respectively). Those who
initiated heroin use by injection had been using heroin for
more years than those who initiated heroin use non-
parenterally (13 years vs 9 years respectively, t379 = 4.36, p
= 0.001).
Route of administration was also associated with ethnic-
ity: 74% of Indigenous participants commenced heroin
use via injection, 69% of 'Australians' and 36% of 'other
Australians' (χ2 = 26.40, p < .001). There were no differ-
ences in the proportion of participants who commenced
heroin use via injecting in terms of gender (males 64%
and females 65%) or level of education (primary educa-
tion 77%, secondary education 64%).Page 3 of 7
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pendently associated with initiation to heroin use via
injecting. Variables entered into the model were age, gen-
der, ethnicity and age at first injection (before or after 18
years). Level of education was not entered into the model
as there were too few participants with only primary
school level of education who commenced heroin use via
a non-parenteral route of administration.
The final model was significant (χ2 = 43.92, 4df, p < .001)
and the Hosmer and Lemeshow test indicated good fit
(χ2= 1.5 6df, p = .96). Gender was not a characteristic
independently associated with route of first heroin injec-
tion and was removed from the model. Participants aged
less than 25 years and 25–30 years were less likely than
those aged 30 years or more to initiate heroin use via
injecting. 'Other Australians' were also less likely to
reported initiating less injecting (Table 1).
Relationship to initiator
Participants were usually taught to inject by a friend
(63%), family member (14%) or their partner (11%). Ten
percent of the sample reported 'other', which was typically
self-taught. Males and females differed significantly in
terms of who taught them to inject (χ2 = 24.75, df = 2, p <
.001; Table 2). Specifically, a greater proportion of
females were taught to inject by their partner than were
males (χ2 = 23.96, df = 1, p < .001), while more males were
taught to inject by a friend (or other) than females (χ2 =
11.77, df = 1, p < .001). The relationship between partici-
pants and their 'initiators' did not differ according age of
first injection, ethnicity or level of education across those
initiated by friends, family or their partner.
Initiating others
Over a third (37%) of participants reported having taught
someone to inject drugs and 17% had done so in the pre-
ceding 12 months. Among those who had ever taught
someone to inject (n = 149), the median numbers of peo-
ple taught was three (range: 1–200) and two (range: 1–
50) in the preceding 12 months.
Similar proportions of males and females reported teach-
ing someone to inject ever (38% vs 37%) and in the pre-
ceding 12 months (16% vs 19%). There was also no
significant difference in terms of ethnicity or mean age of
those who had ever taught someone to inject ever or in the
preceding 12 months. Those who had taught someone
else to inject heroin had been injecting for a greater mean
number of years than the remainder of the sample (13 v.
10 years; t = -3.08, df = 370, p = 0.002). However, this dif-
ference diminished for those who had recently (preceding
12 months) taught someone to inject (11 years for both
groups).
Blood-borne viral infections
Ninety-two percent of participants reported being tested
for HCV infection; 62% in the six months preceding inter-
view and 78% in the 12 months preceding interview. The
median number of weeks since the last test was 19 (range:
1–572 weeks). Two-hundred and thirty-five participants
(59% of the total sample) self-reported being HCV
positive.
Participants who reported being HCV positive initiated
heroin injecting at a younger mean age (19 years, SD 5.7)
than the remainder of the sample (21 years, SD 6.8). HCV
positive participants were more likely to report initiating
heroin use via injecting than those who were HCV nega-
tive (72% vs 58%, χ2 = 9.14, df = 1, p = 0.003). IDUs typ-
ically become infected with HCV early in their injecting
career [30], thus analysis was stratified by years of inject-
ing (≤ 3 years vs >3 years). The relationship remained only
for those who had been injecting for more than three
Table 1: Characteristics of those who first injected heroin, using multivariate logistic regression
Characteristic No. participants %1st injected Adjusted odds ratio 95% CI P
Age
31+ 184 77 - -
25–30 106 60 0.48 0.28–0.83 .008
≤ 24 96 54 0.34 0.19–0.61 <.001
Ethnicity
Australian 269 67 - - -
ATSI 69 74 1.18 0.61–2.26 ns
Other Australians 61 36 0.30 0.16–0.55 <.001
Age 1st injected
≥ 18 164 77 - -
<18 234 56 0.63 0.39–1.02 .059
CI = Confidence intervalPage 4 of 7
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no difference in self reported HCV status between those
who had initiated someone to injecting in the preceding
12 months and those who had not.
Eighty-eight percent of participants had reported being
tested for HIV a median of six months prior to interview
(range <1–144). Of these, seven (2% of the total sample)
reported being HIV positive. One-hundred and forty-
seven participants (37%) reported having been vaccinated
against hepatitis B. There were no differences between
those who reported being vaccinated against hepatitis B
and those who had not in terms of age at first heroin injec-
tion, initial route of administration and initiating some
one else to injecting in the preceding 12 months.
Only a small number of participants (9%) reported hav-
ing used a needle or syringe after someone else in the
month preceding interview. Sharing needles and syringes
was not associated with mean age at initiation to heroin
injection or initial route of heroin administration. More
participants who had recently initiated someone to inject-
ing (i.e. preceding 12 months) reported sharing needles
and syringes (17%) than those who had not recently ini-
tiated someone (8%), though the difference failed to
reach significance (χ2 = 3.51, df = 1, p = .061).
Sharing (borrowing or lending) injection paraphrenia in
the month preceding interview was reported by just over
half (52%) the sample. Participants who had engaged in
this behaviour were more likely to have initiated heroin
use via injecting (71% vs 61%, χ2 = 4.37, df = 1, p < .037)
and to have recently initiated someone to injecting (12%
vs 23%, χ2 = 7.95, df = 1, p < .005) compared to those who
not shared injection paraphernalia. There was no differ-
ence in terms of age at first heroin injection.
Disscussion
This study has identified factors associated with initiation
to heroin injecting. The majority of heroin users com-
menced heroin use via injecting, though those who initi-
ated heroin use via this method had been using heroin for
a longer period than those who initiated heroin use via
non-parenteral methods. Participants were initiated to
injection by a range of people, mainly friends. A large pro-
portion of study participants also reported initiating
another person to heroin injection, a practice that was
associated with longer heroin use careers and recent shar-
ing of injecting equipment.
Increasing attention has been paid to the role of IDUs in
initiation to injecting drug use [15], though few studies
have examined the prevalence of this behaviour. Crofts
and colleagues postulate that the behaviour can be under-
stood as communicable and modelled as in the case of
infectious diseases [20]. Fewer participants in the current
study reported initiating others to injecting than that
reported by Crofts et al. (37% vs 47%) and only 17%
reported doing so in the preceding 12 months. Crofts et al.
sampled only young injecting drug users (i.e. 17–24
years) [20], whereas the injecting experience of partici-
pants sampled for this study ranged from less than one
year to 39 years and younger participants were no more
likely than older participants to report initiating others to
injecting.
A third of the sample initially used heroin by non-
parenteral routes of administration. Participants from eth-
nically diverse backgrounds (i.e. born outside Australia or
identify other than Australian) were more likely than
other participants to have first used heroin by means other
than injecting, which is consistent with other Australian
research which found smoking heroin to be more com-
mon among Indochinese than Caucasian heroin users
[31].
Participants who commenced heroin use via injecting
were also older than those who first used a non-injecting
route of heroin administration, possibly indicating an
overall shift toward non-injecting routes of administra-
tion. A number of interventions aimed at reducing the
incidence of transition to injecting have received attention
[15]. One study found that brief interventions delivered
through existing drug services can have an impact on
injecting drug users' behaviour, however, the study was
modest and further research is warranted [26].
The current study found a direct significant relationship
between current age and age of first heroin use and first
heroin injection. This result is consistent with other Aus-
tralian research [17,18]. Nevertheless the finding is sub-
ject to bias due to 'right censoring' of the data [17]. For
example, an 18 year old recruited into the study cannot
have an age of initiation above 18 years, while a 30 year
old can have any age of initiation up to 30 years, and be
included in the study even if they commenced injecting at
25 years [for a more detailed discussion see [17]]. There
are numerous explanations for this decrease in initiation
to heroin use; the rapid expansion of the Australian her-
oin market between 1996 and 2000, where the price of
heroin decreased concomitant with an increase in purity
and availability from 1996 to 2000 [32], may in part
explain this phenomenon, though greater examination of
the structural determinants of drug use are also warranted
[33].
Although the proportion of participants reporting using a
needle or syringe after another person (sharing) in the
preceding month was low, it is consistent with other
research examining transitions to injecting [31], but lowerPage 5 of 7
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It is possible that the data is subject to a social desirability
bias and thus under-reported. Participants reported com-
paratively high levels of 'indirect' sharing (sharing inject-
ing paraphernalia other than needles and syringes), a
phenomenon recently found to significantly and inde-
pendently increase the risk of HCV transmission [34]. This
behaviour was reported more often by those who reported
teaching someone to inject in the 12 months preceding
interview. That those who are more likely to engage in this
behaviour are also teaching others to inject is cause for
concern, as it has the potential to perpetuate the problem
of injecting related risk taking behaviour among new
recruits.
The majority of the sample believed themselves to be HCV
positive and, not surprisingly, those who injected at a
younger age were more likely to be HCV positive and to
have first used heroin via injection. Though importantly,
there was no difference in terms of HCV status between
those who had recently taught another to inject and those
who had not.
Conclusions
This study has confirmed that initiation to heroin use in
Australia typically occurs via injection, though this is less
apparent among younger heroin uses. The study has also
found that more than a third of heroin users have initiated
others into injecting, with close to a fifth having done so
recently. Many of those who engaged in this behaviour
tended to take greater injection related risks which has
important implications for the transmission of blood-
borne infections. A better understanding of the circum-
stances surrounding the initiation to heroin injection is
needed. Peer-led interventions, which have been found to
be effective in changing IDUs' attitudes and behaviours
[26], may have a role to play in reducing the number of
heroin users initiating others to injecting.
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